What are the emergency anaesthesia drugs, including their intravenous doses, duration of clinical effect, and primary actions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Anaesthesia Drugs: Doses, Onset, and Duration

For emergency airway management and procedural sedation, the core drugs are succinylcholine (2 mg/kg IV, onset 30-45 seconds, duration 5-10 minutes), etomidate (0.2-0.3 mg/kg IV for induction), ketamine (2 mg/kg IV), propofol (2-6 mg/kg IV), midazolam (0.07 mg/kg IV), and rocuronium (0.1-0.2 mg/kg IV, onset 2 minutes, duration 45-90 minutes). 1

Neuromuscular Blocking Agents

Succinylcholine (Depolarizing Agent)

  • IV Dose: 2 mg/kg (4 mg/kg for infants <6 months)
  • IM Dose: 4 mg/kg (5 mg/kg for infants <6 months)
  • Onset: 30-45 seconds IV; 3-5 minutes IM
  • Duration: 5-10 minutes
  • Action: Rapid paralysis for emergency intubation

Critical caveats: Always pretreat with atropine 0.02 mg/kg (minimum 0.1 mg, maximum 1 mg) to prevent bradycardia or asystole. This drug causes life-threatening hyperkalemia in patients with burns, crush injuries, spinal cord injury, neuromuscular disease, or myopathy—use rocuronium instead in these cases. Immediate cardiac arrest after administration suggests hyperkalemia, particularly in boys <9 years old. 1

Rocuronium (Nondepolarizing Agent)

  • IV Dose: 0.1 mg/kg for routine paralysis; 0.2 mg/kg for intubation
  • Onset: 2 minutes (slower than succinylcholine)
  • Duration: 45-90 minutes (dose-dependent)
  • Action: Longer-acting paralysis

Rocuronium is preferred when succinylcholine is contraindicated but requires 2 minutes for adequate intubating conditions versus 30-45 seconds for succinylcholine. 1

Vecuronium (Nondepolarizing Agent)

  • IV Dose: 0.1 mg/kg for routine paralysis; 0.2 mg/kg for intubation
  • Onset: 2 minutes
  • Duration: 45-90 minutes
  • Action: Alternative nondepolarizing agent with minimal cardiovascular effects

Used when longer paralysis is needed; preferred over rocuronium in some settings due to simple storage and lack of adverse effects. 2

Induction Agents

Etomidate

  • IV Dose: 0.2-0.3 mg/kg
  • Onset: Rapid (seconds)
  • Duration: Short-acting
  • Action: Induction with cardiovascular stability

Etomidate is the preferred induction agent for patients with cardiovascular dysfunction or volume depletion due to hemodynamic stability. 1 It can be safely administered for procedural sedation in the ED (Level C recommendation). 3 Common side effects include pain on injection and myoclonus (0-21% of patients, usually <1 minute duration). 3 The main concern is potential adrenal insufficiency with repeated dosing. 4

Ketamine

  • IV Dose: 2 mg/kg (after 0.07 mg/kg midazolam pretreatment in adults)
  • Onset: Rapid
  • Duration: Variable
  • Action: Dissociative anesthesia with analgesia

Ketamine can be safely administered to children for procedural sedation (Level A recommendation). 3 It is indicated for analgesia and anesthesia in trauma patients, except those with isolated or dominant craniocerebral trauma. 2 When combined with midazolam (0.07 mg/kg IV followed by ketamine 2 mg/kg IV), it provides effective sedation with minimal emergence reactions in adults. 3

Propofol

  • IV Dose: 2-6 mg/kg
  • Onset: Rapid (seconds)
  • Duration: Short-acting (minutes)
  • Action: Rapid induction and sedation

Propofol can be safely administered for procedural sedation (Level B recommendation). 3 Use lower doses if other sedatives/narcotics have been administered. Causes vasodilation and decreased cardiac output; higher doses associated with hypotension and apnea. Avoid in patients with cardiovascular dysfunction or volume depletion—use etomidate instead. 1 IM administration causes tissue necrosis. 1

Sedatives and Analgesics

Midazolam

  • IV Dose: 0.07 mg/kg (for procedural sedation)
  • Onset: 1-3 minutes
  • Duration: 30-60 minutes
  • Action: Anxiolysis, amnesia, sedation

The combination of fentanyl and midazolam is effective for procedural sedation (Level B recommendation). 3 Midazolam is used for sedation alone or in combination with ketamine or fentanyl for total intravenous anesthesia. 2 Recent evidence shows both intramuscular and intravenous routes are effective for acute agitation, though IV may require more active airway management. 5

Fentanyl

  • IV Dose: Titrate to effect (average 180 mcg, range 25-1,400 mcg in ED studies)
  • Onset: 1-2 minutes
  • Duration: 30-60 minutes
  • Action: Potent opioid analgesia

Fentanyl is safe when carefully dosed and titrated; respiratory compromise occurs in 0.7% of patients. 3 Mainly used for total intravenous anesthesia with controlled ventilation. 2 Naloxone must be immediately available. 3

Morphine

  • IV Dose: Titrate to effect
  • Onset: 5-10 minutes
  • Duration: 3-4 hours
  • Action: Opioid analgesia for major pain

Indicated for treatment of major pain, especially in internal medicine patients. 2

Critical Safety Requirements

All neuromuscular blocking agents require:

  • Immediate availability of personnel skilled in airway management
  • Age-appropriate equipment for suctioning, oxygenation, intubation, and ventilation
  • Ventilatory support capability
  • These drugs provide NO sedation, analgesia, or amnesia 1

For procedural sedation:

  • Nondissociative sedation agents should be titrated to clinical effect to maximize safety (Level B recommendation). 3
  • Respiratory depression is the most concerning side effect, but careful preparation and administration prevent harmful sequelae. 3
  • Oxygen saturation monitoring is mandatory
  • Flush IV line with saline before administering rocuronium or vecuronium to avoid precipitation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.